Ascendis Pharma A/S - ADR (ASND)

Q3 2019 13F Holders as of 30 Sep 2019

Type / Class
Equity / ADR
Shares outstanding
55,574,229
Number of holders
127
Total 13F shares, excl. options
46,122,563
Shares change
-1,480,588
Total reported value, excl. options
$4,442,511,426
Value change
-$194,325,083
Put/Call ratio
17%
Number of buys
68
Number of sells
-60
Price
$96.32

Significant Holders of Ascendis Pharma A/S - ADR (ASND) as of Q3 2019

157 filings reported holding ASND - Ascendis Pharma A/S - ADR as of Q3 2019.
Ascendis Pharma A/S - ADR (ASND) has 127 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 46,122,563 shares of 55,574,229 outstanding shares and own 83% of the company stock.
Largest 10 shareholders include PRICE T ROWE ASSOCIATES INC /MD/ (7,774,992 shares), FMR LLC (4,754,520 shares), RA CAPITAL MANAGEMENT, L.P. (4,132,442 shares), ORBIMED ADVISORS LLC (3,719,173 shares), BAKER BROS. ADVISORS LP (3,390,270 shares), Artisan Partners Limited Partnership (2,139,665 shares), Avoro Capital Advisors LLC (1,970,000 shares), EVENTIDE ASSET MANAGEMENT, LLC (1,698,648 shares), FARALLON CAPITAL MANAGEMENT LLC (1,550,000 shares), and WESTFIELD CAPITAL MANAGEMENT CO LP (1,124,054 shares).
This table shows the top 127 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.